Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (9 ops.)
Latest filing published 29 Jun 2026 for CVS HEALTH Corp.
Filing timeline
BuySaleJames David Clark
Insider track record
Disclosed buys
0
Disclosed sells
9
Signal history
James David Clark: trading record in brief
James David Clark, SVP, Cont & Chief Acct Officer at CVS Health Corp, has filed 9 sales for EUR 3.8 million, a median of EUR 346,667, and no purchase. The largest, EUR 1,582,613, dates from August 3, 2023; next come EUR 592,473 on January 28, 2022 and EUR 469,077 on March 5, 2025.
The record counts 52 filings, published from March 1, 2019 to June 29, 2026, among them 38 grants and 5 option exercises. The volume is 10 filings in 2022, the busiest year, then 5 to 6 a year from 2023 to 2025 and 3 in 2026. Four filings fall in the last twelve months, with no sale. Publication comes a median of 2 days after the trade, across 51 dated filings.
CVS Health Corp is the only issuer. Jonathan C. Roberts is within 30 days of 3 of Clark's market trades, Alan Lotvin of 3 (1 in the same direction), Jonathan E. Mayhew and Larry J. Merlo of 2 each and Eva C. Boratto of 1.
Companies and markets linked to James David Clark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations52 total
454 sharesCommon Stock (Restricted)SEC:0000064803-26-000092:0
11,138 shares@ US$71.8223.8% of flowCommon Stock (Restricted)SEC:0000064803-26-000036:0
3,262 shares@ US$72.497.0% of flowCommon StockSEC:0000064803-26-000036:1
220 shares@ US$79.100.5% of flowCommon Stock (Restricted)SEC:0000064803-25-000079:0
14,710 shares@ US$67.988.2% of flowCommon Stock (Restricted)SEC:0001127602-25-011394:1
2,266 shares@ US$67.984.9% of flowCommon StockSEC:0001127602-25-011394:0
7,513 shares@ US$66.354.1% of flowCommon StockSEC:0001127602-25-008726:1
7,513 shares@ US$62.2115.1% of flowCommon StockSEC:0001127602-25-008726:0
86 shares@ US$59.850.2% of flowCommon StockSEC:0001127602-24-028492:0
1,112 shares@ US$79.560.7% of flowCommon StockSEC:0001127602-24-012275:1
10,683 shares@ US$79.567.0% of flowCommon Stock (Restricted)SEC:0001127602-24-012275:2
1,892 shares@ US$79.564.8% of flowCommon StockSEC:0001127602-24-012275:0
2,452 shares0Common StockSEC:0001127602-24-005071:0
122 shares@ US$68.480.3% of flowCommon Stock (Restricted)SEC:0001127602-23-029716:0
23,128 shares@ US$74.9413.9% of flowCommon StockSEC:0001127602-23-022036:1
2,631.255 shares@ US$74.796.2% of flowCommon StockSEC:0001127602-23-022036:0
2,186 shares@ US$74.311.3% of flowCommon Stock (Restricted)SEC:0001127602-23-012216:1
1,471 shares@ US$74.313.4% of flowCommon StockSEC:0001127602-23-012216:0
179 shares@ US$83.540.5% of flowCommon StockSEC:0001127602-23-007949:0
153 shares@ US$101.650.5% of flowCommon StockSEC:0001127602-22-026782:0
266 shares@ US$88.780.7% of flowCommon Stock (restricted)SEC:0001127602-22-023944:0
2,740 shares@ US$101.092.2% of flowCommon StockSEC:0001127602-22-011609:1
3,214 shares@ US$101.092.6% of flowCommon Stock (restricted)SEC:0001127602-22-011609:2
3,897 shares@ US$101.0912.2% of flowCommon StockSEC:0001127602-22-011609:0
253 shares@ US$103.650.2% of flowCommon StockSEC:0001127602-22-007421:1
25 of 52 declarations
